1. The invention relates to compounds of formula (I) which are used to produce drugs for prophylaxis and therapy of all conditions whose development is associated to an increased level of interleukin-1$g(b), e.g. septic shock, leukaemia, hepatitis, amyotrophy, HIV infections or degenerative disorders of joints, such as arthrosis, spondylosis, chondrolysis following traumatic joint injury or prolonged immobilisation of joints following meniscus or knee cap injuries or ligament tears, or conjunctiva tissue conditions such as collagen disease, parodontium disease, wound healing disorders and chronic disease of the motility system, such as infectious, immunologic or metabolism-related acute and chronic arthritis, arthropathy, rheumatoid arthritis, myalgia and bone metabolism disorders.